BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 30, 2010
View Archived Issues
Identification of HIV integrase inhibitor BMS-727740 described by Bristol-Myers Squibb
Read More
H1N1 vaccine Pandemrix fails to provide protection in kidney transplant recipients
Read More
PSN-632408 stimulates replication of beta-cells in preclinical study
Read More
Marina Biotech sells carbetocin assets to Cypress Bioscience
Read More
ADX-71149 completes phase I program and moves towards phase II
Read More
ADDF awards grant to AgeneBio to develop neural stabilizer technology
Read More
Kyowa Hakko Kirin to conduct KW-2246 trials for cancer pain in Japan
Read More
Tasigna approved in Switzerland for Ph+ chronic myeloid leukemia
Read More
Bioheart reports improvements in heart failure patients
Read More
Pharmagenesis identifies new triptolide compounds
Read More
European Commission updates license for Cervarix HPV vaccine
Read More
EMA investigates potential relationship between Pandemrix and narcolepsy
Read More
Otsuka Pharmaceutical Factory claims new lipoprotein lipase-activating agents
Read More
Daiichi Sankyo reports first quarter highlights of fiscal 2010
Read More
Exelixis discovers new inhibitors of ceramide glucosyltransferase
Read More
Vitae Pharmaceuticals discloses novel 11beta-HSD1 inhibitors
Read More
Astellas Pharma identifies new serotonin 5-HT5A receptor ligands
Read More
Schering presents new agonists of free fatty acid receptor 1
Read More
Abbott and Eisai submit application for new indication of Humira in JIA
Read More
Results reported from phase II trial of cariprazine in bipolar depression
Read More
Sanofi-aventis submits proposal to acquire Genzyme
Read More
Merck KGaA begins phase Ib trial of IMO-2055 in SCCHN
Read More
Asenapine exposure increased in older patients with psychotic symptoms
Read More
Risperidone may have the potential to treat alcohol dependence
Read More
Antitope and Ablynx to collaborate in developing Nanobodies
Read More